AI Tackles Dementia: Punto Health Secures $2.7 Million Seed Funding
December 16, 2025, 3:39 pm
London-based Punto Health just secured $2.7 million. This seed funding will fuel expansion. The company focuses on AI-powered dementia care. Their platform aims to shift care from reactive to proactive. It connects patients, caregivers, and clinicians. Early detection is key. Personalized support is central. The platform boasts three core products: PuntoTest, PuntoCare, and PuntoClinic. PuntoTest uses AI to assess cognitive impairment. PuntoCare offers daily support and tracking. PuntoClinic provides data-driven insights for clinicians. Trials are underway in the UK and Spain. Over 2,000 users have participated. The company emphasizes co-design with clinical partners. Investors include Shilling VC and Plus Partners. Punto Health aims to ease the burden on families. They want to improve dementia care access. The platform supports multiple languages. It offers cognitive exercises and wellness guidance. The company is gaining recognition within the health tech space. They are finalists for multiple awards. Their goal: a trusted companion for dementia patients and their families. This funding marks a significant step. It signals growing investment in AI-driven healthcare solutions. The platform’s success hinges on continued clinical validation. Expansion will be focused on London and Barcelona. The company’s founders are committed to diversity in tech. They aim to build a team reflecting the real world.
Punto Health, a London-based digital health startup, received $2.7 million in seed funding. The investment will accelerate platform development. Expansion plans target the UK and Spain. Shilling VC and Plus Partners co-led the round. Several other investors participated.
Dementia care is often fragmented. It’s frequently reactive, not proactive. Punto Health aims to change this. Their platform connects patients, caregivers, and doctors. It provides personalized support. Early detection is a core focus.
The company’s platform has three key components. PuntoTest uses AI to assess cognitive function. It analyzes speech patterns. This offers a non-invasive assessment. PuntoCare is a companion app. It provides daily support. Features include care plans and cognitive exercises. PuntoClinic is a dashboard for clinicians. It aggregates patient data. This enables data-driven decisions.
Clinical validation is crucial. Punto Health partnered with Ace Alzheimer Centre Barcelona. They co-designed the platform. Trials are ongoing in multiple locations. These include hospitals and pharmacies. Over 1,500 participants have been involved.
The platform currently supports over 200 users. They range in age from 60 to 90. Users have completed over 30,000 activities. Many report improved confidence. Managing daily routines is easier.
Punto Health emphasizes user feedback. Patients, caregivers, and clinicians shaped the platform. This ensures it meets real-world needs. The company is also focused on diversity. They want to build a representative team.
The funding will support hiring. New roles will be based in London and Barcelona. Punto Health is a finalist for the Premios Discapnet award. They are also part of several accelerator programs. These include AD Moonshot and the AI-First Google Accelerator.
This investment highlights a growing trend. AI is transforming healthcare. Dementia care is a critical area. Punto Health’s platform offers a promising solution. It aims to improve lives. It provides support for families. It empowers clinicians. The future of dementia care may be proactive. It may be personalized. It may be powered by AI.
Punto Health, a London-based digital health startup, received $2.7 million in seed funding. The investment will accelerate platform development. Expansion plans target the UK and Spain. Shilling VC and Plus Partners co-led the round. Several other investors participated.
Dementia care is often fragmented. It’s frequently reactive, not proactive. Punto Health aims to change this. Their platform connects patients, caregivers, and doctors. It provides personalized support. Early detection is a core focus.
The company’s platform has three key components. PuntoTest uses AI to assess cognitive function. It analyzes speech patterns. This offers a non-invasive assessment. PuntoCare is a companion app. It provides daily support. Features include care plans and cognitive exercises. PuntoClinic is a dashboard for clinicians. It aggregates patient data. This enables data-driven decisions.
Clinical validation is crucial. Punto Health partnered with Ace Alzheimer Centre Barcelona. They co-designed the platform. Trials are ongoing in multiple locations. These include hospitals and pharmacies. Over 1,500 participants have been involved.
The platform currently supports over 200 users. They range in age from 60 to 90. Users have completed over 30,000 activities. Many report improved confidence. Managing daily routines is easier.
Punto Health emphasizes user feedback. Patients, caregivers, and clinicians shaped the platform. This ensures it meets real-world needs. The company is also focused on diversity. They want to build a representative team.
The funding will support hiring. New roles will be based in London and Barcelona. Punto Health is a finalist for the Premios Discapnet award. They are also part of several accelerator programs. These include AD Moonshot and the AI-First Google Accelerator.
This investment highlights a growing trend. AI is transforming healthcare. Dementia care is a critical area. Punto Health’s platform offers a promising solution. It aims to improve lives. It provides support for families. It empowers clinicians. The future of dementia care may be proactive. It may be personalized. It may be powered by AI.